The role of the extracellullar calcium-sensing receptor in health and disease

Experimental and Clinical Endocrinology and Diabetes

Volumn 114, Issue 8, 2006, Pages 397-405

  Raue, Friedhelm ^a,b   Haag, C ^a   Schulze, E ^a   Frank Raue, K ^a  

^a Endocrine Practice   (Germany)

^b Endokrinologische Gemeinschaftspraxis   (Germany)

Author keywords

Autosomal dominant hypocalcaemia; Calcium sensing receptor; Familial hypocalciuric hypercalcaemia

Indexed keywords

CALCIUM; CALCIUM SENSING RECEPTOR; PARATHYROID HORMONE;

AUTOIMMUNE DISEASE; AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL DOMINANT HYPOCALCEMIA; BARTTER SYNDROME; CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; CALCIUM URINE LEVEL; DNA POLYMORPHISM; EXTRACELLULAR CALCIUM; FAMILIAL BENIGN HYPOCALCIURIA HYPERCALCEMIA; GENE FUNCTION; GENE MUTATION; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; HYPERCALCEMIA; HYPOCALCEMIA; HYPOCALCIURIA; KIDNEY CALCIFICATION; NEPHROLITHIASIS; PARATHYROID GLAND; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; URINARY EXCRETION; ADULT; CHEMISTRY; GENETICS; HYPERPARATHYROIDISM; HYPOPARATHYROIDISM; KIDNEY; NEWBORN; PATHOPHYSIOLOGY; PHYSIOLOGY; REFERENCE VALUE; URINE;

ADULT; CALCIUM; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPOCALCEMIA; HYPOPARATHYROIDISM; INFANT, NEWBORN; KIDNEY; RECEPTORS, CALCIUM-SENSING; REFERENCE VALUES;

EID: 33750355442     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-924315     Document Type: Review

References (97)

1. Adams GB, Chabner KT, Alley IR, Olson DP, Szczepiorkowski ZM, Poznansky MC, Kos CH, Pollak MR, Brown EM, Scadden DT. Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature 2006; 439: 599-603
2. Aida K, Koishi S, Inoue M, Nakazato M, Tawata M, Onaya T. Familial hypocalciuric hypercalcemia associated with mutation in the human Ca(2+)-sensing receptor gene. J Clin Endocrinol Metab 1995a; 80: 2594-2598
3. Aida K, Koishi S, Tawata M, Onaya T. Molecular cloning of a putative Ca(2+)-sensing receptor cDNA from human kidney. Biochem Biophys Res Commun 1995b; 214: 524-529
4. Andrade SC, Kohara SK, D'Souza-Li L. A Novel Mutation in the Calcium-Sensing Receptor in Familiar Hypocalciuric Hypercalcemia and Neonatal Severe Hyperparathyroidism. 2004; ASBMR 26th Annual Meeting of the American Society for Bone and Mineral Research, Abstract SA 542
5. Bai M, Pearce SHS, Kifor O, Trivedi S, Stauffer UG, Thakker RV, Brown EM, Steinmann B. In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: Normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia. J Clin Invest 1997a; 99: 88-96
6. Bai M, Janicic N, Trivedi S, Quinn SJ, Cole DE, Brown EM, Handy GN. Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. J Clin Invest 1997b; 99: 1917-1925
7. Baron J, Winer KK, Yanovski JA, Cunningham AW, Laue L, Zimmermann D, Cutler GB. Mutations in the Ca(2+)-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism. Hum Mol Genet 1996; 5: 601-606
8. Block G, Martin K, de Francisco A, Turner S, Avram M, Suranyi M, Hercz G, Cunningham J, Abu-Alfa A, Messa P, Coyne D, Locatelli F, Cohen R, Evenepoel P, Moe S, Fournier A, Braun J, McCary L, Zani V, Olson K, Drueke T, Goodman W. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 2004; 350: 1516-1525
9. Boonstra CE, Jackson CE. Serum calcium survey for hyperparathyroidism. Am J Clin Pathol 1971; 55: 523-525
10. Brown EM, Mclead RJ. Extracellular calcium-sensing and extracellular calcium signalling. Physiol Rev 2001; 81: 239-297
11. Brown EM. Mutant extracellular calcium-sensing receptors and severity of disease. J Clin Endocrinol Metab 2005; 90: 1246-1248
12. Burski K, Torjussen B, Paulsen AQ, Boman H, Bollerslev J. Parathyroid adenoma in a subject with familial hypocalciuric hypercalcemia: coincidence or causality? J Clin Endocrinol Metab 2002; 87: 1015-1016
13. Catling T, Szabo E, Gustavsson P, Westin G, Hellman P, Akerstrom G, Dahl N, Rastad J. Mutation in the calcium-sensing receptor gene in autosomal dominant hypercalcemia with hypercalciuria. 80th Annual Meeting of The Endocrine Society, 1998
14. Cetani F, Pardi E, Borsari S, Tonacchera M, Morabito E, Pinchera A, Marcocci C, Dipollina G. Two Italian kindreds with familial hypocalciuric hypercalcaemia caused by loss-of-function mutations in the calcium-sensing receptor (CaR) gene: functional characterization of a novel CaR missense mutation. Clin Endocrinol (Oxf) 2003; 58: 199-206 .
15. Erratum in: Clin Endocrinol (Oxf) 2003; 58: 671
16. Chikatsu N, Fukumoto S, Suzawa M, Tanaka Y, Takeuchi Y, Takeda S, Tamura Y, Matsumoto T, Fujita T. An adult patient with severe hypercalcaemia and hypocalciuria due to a novel homzoygous inactivating mutation of calcium-sensing receptor. Clinical Endocrinology 1999; 50: 537-543
17. Chou YH, Pollak MR, Brandi ML, Toss G, Arnquist H, Atkinson AB, Papapoulos SE, Marx S, Brown EM, Seidman JG. Mutations in the human Ca(2+)-sensing-receptor gene that cause familial hypocalciuric hypercalcemia. Am J Hum Genet 1995; 56: 1075-1079
18. Cole DEC, Janicic N, Salisbury SR, Handy GN. Neonatal severe hyperparathyroidism, secondary hyperparathyroidism, and familial hypocalciuric hypercalcemia: multiple different phenotypes associated with an inactivation ALU insertion mutation of the calcium-sensing receptor gene. Am J Med Genet 1997; 71: 202-210
19. Cole D, Peltekova V, Rubin L, Hawker G, Vieth R, Liew C, Hwang D, Evrovski J, Hendy G. A986S polymorphism of the calcium-sensing receptor and circulating calcium concentrations. Lancet 1998; 353: 112-115
20. Cole D, Vieth R, Trang H, Wong B, Hendy G, Rubin L. Association between total serum calcium and the A986S polymorphism of the calcium-sensing receptor gene. Mol Gen Metab 2001; 72: 168-174
21. Cole DR, Soule S, Raizis A, George P. Hypocalcemia and a novel calcium sensing receptor activating mutation. The Royal Australasian College of Physicians Annual Scientific Meeting 2005
22. Conley YP, Finegold DN, Peters DG, Oppenheim JS, Ferrel RE. Three novel activating mutations in the calcium-sensing receptor responsible for autosomal dominant hypocalcemia. Molecular Genetics and Metabolism 2000; 71: 591-598
23. De Luca F, Mancilla RK, Fan GF, Winer KK, Gore P, Spiegel AM, Baron J. Sporadic hypoparathyroidism caused by de novo gain-of-function mutations of the Ca2+-sensing receptor. J Clin Endocrinol Metab 1997; 82: 2710-2715
24. Dreimane D, Hendy G, Alon U, Geffner M. Normalization of Serum Calcium, Phosphorus and Magnesium with homeopathic PTH in a child with Hypocalcemic Hypercalciuria (HCHC) and a mutation of the Calcium-Sensing Receptor Gene. 83rd Annual Meeting of the Endocrine Society 2001
25. D'Souza-Li L, Canaff L, Janicic N, Cole DE, Hendy GN. An acceptor splice site mutation in the calcium-sensing receptor (CASR) gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Hum Mutat 2001; 18: 411-421
26. D'Souza-Li L, Yang B, Canaff L, Bai M, Hanley DA, Bastepe M, Salisbury SR, Brown EM, Cole DE, Hendy GN. Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia. J Clin Endocrinol Metab 2002; 87: 1309-1318
27. Felderbauer P, Hoffmann P, Klein W, Bulut K, Ansorge N, Epplen JT, Schmitz F, Schmidt WE. Identification of a novel calcium-sensing receptor gene mutation causing familial hypocalciuric hypercalcemia by single-strand conformation polymorphism analysis. Exp Clin Endocrinol Diabetes 2005; 113: 31-34
28. Fukumoto S, Chikatsu N, Okazaki R, Takeuchi Y, Tamura Y, Murakami T, Obara T, Fujita T. Inactivating mutations of calcium-sensing receptor results in parathyroid lipohyperplasia. Diagn Mol Pathol 2001; 10: 242-247
29. Fuleihan GH. Familial benign hypocalciuric hypercalcemia. J Bone Miner Res 2002; 17: N51-56
30. Haag C, Schulze E, Lorenz A, Frank-Raue K, Raue F. Novel Mutations of the Calcium-Sensing Receptor in Familial Hypocalciuric Hypercalcemia and Autosomal Dominant Hypocalcemia, 87th Annual Meeting of The Endocrine Society, 2005
31. Heath H III. Familial benign (hypocalciuric) hypercalcemia. A troublesome mimic of hyperparathyroidism. Endocrinol Metab Clin North Am 1989; 18: 723-740
32. Heath H III, Jackson CE, Otterud B, Leppert MF. Genetic linkage analysis in familial benign (hypocaliuric) hypercalcemia: evidence for locus heterogeneity. Am J Hum Genet 1993; 53: 193-200
33. Heath H, Odelberg S, Jackson CE, Teh BT, Hayward N, Larsson C, Buist NR, Krapcho KJ, Hung BC, Capuano IV, Garrett JE, Leppert MF. Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains. J Clin Endocrinol Metab 1996; 81: 1312-1317
34. Hendy GN, D'Souza-Li L, Yang B, Canaff L, Cole DE. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum Mutat 2000; 16: 281-296
35. Hendy GN, Minutti C, Canaff L, Pidasheva S, Yang B, Nouhi Z, Zimmerman D, Wei C, Cole DE. Recurrent familial hypocalcemia due to germline mosaicism for an activating mutation of the calcium-sensing receptor gene. J Clin Endocrinol Metab 2003; 88: 3674-3681
36. Hinnie J, Bell E, McKillop E, Gallacher S. The prevalence of familial hypocalciuric hypercalcemia. Calcif Tissue Int 2001; 68: 216-218
37. Hirai H, Nakajima S, Miyauchi A, Nishimura K, Shimizu N, Shima M, Michigami T, Ozono K, Okada S. A novel activating mutation (C129S) in the calcium-sensing receptor gene in a Japanese family with autosomal dominant hypocalcemia. J Hum Genet 2001; 46: 41-44
38. Hu J, Mora S, Colussi G, Proverbio MC, Jones KA, Bolzoni L, De Ferrari ME, Civati G, Spiegel AM. Autosomal dominant hypocalcemia caused by a novel mutation in the loop 2 region of the human calcium receptor extracellular domain. J Bone Miner Res 2002; 17: 1461-1469
39. 2+-sensing receptor, implications for its structure and function. Trends Endocrinol Metab 2003; 14: 282-288
40. Hu J, Mora S, Weber G, Zamproni I, Proverbio MC, Spiegel AM. Autosomal dominant hypocalcemia in monozygotic twins caused by a de novo germline mutation near the amino-terminus of the human calcium receptor. J Bone Miner Res 2004; 19: 578-586
41. Hu J, McLarnon SJ, Mora S, Jiang J, Thomas C, Jacobson KA, Spiegel AM. A region in the seven-transmembrane domain of the human Ca2+ receptor critical for response to Ca2+. J Biol Chem 2005; 280: 5113-5120
42. Inoue D, Saika M, Ikeda Y, Matsumoto T. Successful treatment of hypoparathyroidism caused by a novel calcium-sensing receptor mutation with thiazide diuretics and low dose alfacalcidol. Bone 1998; 23: 382
43. Janicic N, Pausova Z, Cole DE, Hendy GN. Insertion of an Alu sequence in the Ca(2+)-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Am J Hum Genet 1995; 56: 880-886
44. Jap T, Wu Y, Jenq S, Won G. A novel mutation in the calcium-sensing receptor gene in a Chinese subject with persistent hypercalcemia and hypocalciuria. J Clin Endocrinol Metab 2001; 86: 13-15
45. Kifor O, Moore FD, Delaney M, Garber J, Hendy GN, Butters RR, Gao P. Couter TL, Kifor I, Brown EM, Wysolmerki J. A syndrome of hypocalciuric hypercalcemia caused by auto-antibodies directed at the calcium-sensing receptor. J Clin Endocrinol Metab 2003; 88: 60-72
46. Kobayashi M, Tanaka H, Tsuzuki K, Tsuyuki M, Igaki H, Ichinose Y, Aya K, Nishioka N, Seino Y. Two novel missense mutations in calcium-sensing receptor gene associated with neonatal severe hyperparathyroidism. J Clin Endocrinol Metab 1997; 82: 2716-2719
47. Konrad M, Weber S. Recent advances in molecular genetics of hereditary magnesium-losing disorders. J Am Soc Nephrol 2003; 14: 249-253
48. Lam CW, Lee KF, Chan AO, Poon PM, Law TY, Tong SF. Novel missense mutation in the CASR gene in a Chinese family with familial hypocalciuric hypercalcemia. Clin Chim Acta 2005; 360: 167-172
49. Law WM Jr, Heath H III. Familial benign hypercalcemia (hypocalciuric hypercalcemia) - clinical and pathogenetic studies in 21 families. Ann Intern Med 1985; 102: 511-519
50. Li Y, Song YH, Rais N, Connar E, Schatz D, Mair A, Maclaren N. Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism. J Clin Invest 1996; 97: 910-914
51. Lienhardt A, Garabedian M, Bai M, Sinding C, Zhang Z, Lagarde J, Boulesteix J, Rigaud M, Brown EM, Kottler M. A large homozygous or heterozygous in-frame deletion within the calcium-sensing receptor's carboxylterminal cytoplasmic tail that causes autosomal dominant hypocalcemia. J Clin Endocrinol Metab 2000; 85: 1695-1702
52. Lienhardt A, Bai M, Lagarde JP, Rigaud M, Zhang Z, Jiang Y, Kottler ML, Brown EM, Garabedian M. Activating mutations of the calcium-sensing receptor: management of hypocalcemia. J Clin Endocrinol Metab 2001; 86: 5313-5323
53. Lovlie R, Eiken HG, Sorheim JI, Boman H. The Ca(2+)-sensing receptor gene (PCAR1) mutation T151 M in isolated autosomal dominant hypoparathyroidism. Hum Genet 1996; 98: 129-133
54. OK) to chromosome 19q13. Am J Hum Genet 1999; 64: 189-195
55. Marcocci C, Cetani F, Borsari B, Pardi E, Dipollina G, Ambrogini E, Cianferotti L, Viccica G, Pinchera A. Hypercalcemia in a Women with Breast Cancer Misdiagnosed as Hypercalcemia of Malignancy: An Unusual Presentation of Familial Hypocalciuric Hypercalcemia. ASBMR 25th Annual Meeting of the American Society for Bone and Mineral Research 2003, Abstract SU 456
56. Marx SJ, Attie MF, Levine MA, Spiegel AM, Downs RW, Lasker RD. The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds. Medicine (Baltimore) 1981; 60: 397-412
57. Miyashiro K, Kasamatsu TS, Steinmetz L, de Menezes Filho HC, Damiani D, Setian N, Hauache OM. Identification and functional analysis of a novel inactivating mutation (A804D) of the calcium-sensing receptor gene. Clin Endocrinol (Oxf) 2004a; 61: 780-782
58. Miyashiro K, Kunii I, Manna TD, de Menezes Filho HC, Damiani D, Setian N, Hauache OM. Severe hypercalcemia in a 9-year-old Brazilian girl due to a novel inactivating mutation of the calcium-sensing receptor. J Clin Endocrinol Metab 2004b; 89: 5936-5941
59. Nagase T, Murakami T, Tsukada T, Kitamura R, Chikatsu N, Takeo H, Takata N, Yasuda H, Fukumoto S, Tanaka Y, Nagata N, Yamaguchi K, Akatsu T, Yamamoto M. A family of autosomal dominant hypocalcemia with a positive correlation between serum calcium and magnesium: identification of a novel gain of function mutation (Ser[820]Phe) in the calcium-sensing receptor. J Clin Endocrinol Metab 2002; 87: 2681-2687
60. Nakayama T, Minato M, Nakagawa M, Soma M, Tobe H, Aoi N, Kosuge K, Sato M, Ozawa Y, Kanmatsuse K, Kokubun S. A novel mutation in Ca2+-sensing receptor gene in familial hypocalciuric hypercalcemia. Endocrine 2001; 15: 277-282
61. Nemeth EF, Steffey ME, Hammerland LG, Hung BC, van Wagenen BC, DelMar EG, Balandrin MF. Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc Natl Acad Sci USA 1998; 95: 4040-4045
62. Okazaki R, Chikatsu N, Nakatsu M, Takeuchi Y, Ajima M, Miki J, Fujita T, Ara M, Totsuka Y, Tanaka K, Fukumoto S. A novel activating mutation in calcium-sensing receptor gene associated with a family of autosomal dominant hypocalcemia. J Clin Endocrinol Metab 1999; 84: 363-366
63. Pallais JC, Kifor O, Chen YB, Slovik D, Brown EM. Acquired hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor. N Engl J Med 2004; 351: 362-369
64. Pearce SHS, Trump D, Wooding C, Besser GM, Chew SL, Grant DB, Heath DA, Hughes IA, Paterson CR, Whyle MP, Thakker RV. Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. J Clin Invest 1995; 96: 2683-2692
65. Pearce SHS, Williamson C, Kifor O, Bai M, Coulthard MG, Davies M, Lewis-Barned N, McCredie D, Powell H, Kendall-Taylor P, Brown EM, Thakker RV. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 1996a; 335: 1115-1122
66. Pearce SHS, Bai M, Quinn SJ, Kifor O, Brown EM, Thakker RV. Functional characterization of calcium-sensing receptor mutations expressed in human embryonic kidney cells. J Clin Invest 1996b; 98: 1860-1866
67. Pearce SHS, Wooding C, Davies M, Tollefsen SE, Whyte MP, Thakker RV. Calcium-sensing receptor mutations in familial hypocalciuric hypercalcaemia with recurrent pancreatitis. Clin Endocrinol (Oxf) 1996c; 45: 675-680
68. Pearce SHS. Clinical disorders of extracellular calcium-sensing and the molecular biology of the calcium-sensing receptor. Ann Med 2002; 34: 201-206
69. Pollak MR, Brown EM, Chou YH, Herbert SC, Marx SJ, Steinmann B, Levi T, Seidman CE, Seidman JG. Mutations in the human Ca2+-sensing receptor gene causes familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 1993; 75: 1297-1303
70. Pollak MR, Chou YH, Marx SJ, Steinmann B, Cole DE, Brandi ML, Papapoulos SE, Menko FH, Hendy GN, Brown EM, Seidman CE, Seidman JG. Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J Clin Invest 1994a; 93: 1108-1112
71. Pollak MR, Brown EM, Estep HL, McLaine PN, Kifor O, Park J, Hebert SC, Seidman CE, Seidman JG. Autosomal dominant hypocalcaemia caused by a Ca2+-sensing receptor gene mutation. Nat Genet 1994b; 8: 303-307
72. Rajguru M, Bedu A, Magdelaine C, Bai M, Aujuard Y, Lienhardt A. Neonatal primary hyperparathyroidism due to a new calcium sensing receptor mutation. Pediatric Academic Societies' 2001 Annual Meeting, Abstract P3-294
73. 2+ receptor critical for dimerization. J Biol Chem 1999; 274: 27642-27650
74. Schwarz P, Larsen NE, Lonborg Friis IM, Lillquist K, Brown EM, Gammeltoft S. Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism associated with mutations in the human Ca2+-sensing receptor gene in three Danish families. Scand J Clin Lab Invest 2000; 60: 221-227
75. Scillitani A, Guarnirei V, de Geronimo S, Muscarella LA, Battista C, D'Agruma L, Bertoldo F, Florio C, Minisola S, Hendy G, Cole D. Blood ionized calcium is associated with clustered polymorphisms in the carboxyl-terminal tail of the calcium-sensing receptor. J Clin Endocrinol Metab 2004; 89: 5634-5638
76. Shiohara M, Mori T, Mei B, Brown EM, Watanabe T, Yasuda T. A novel gain-of-function mutation (F821 L) in the transmembrane domain of calcium-sensing receptor is a cause of severe sporadic hypoparathyroidism. Eur J Pediatr 2004; 163: 94-98
77. Silver J, Naveh-Many T. Regulation of parathyroid hormone synthesis and secretion. Semin Nephrol 1994; 14: 175-194
78. Silverberg SJ, Bone HG III, Mariott TB, Locker FG, Thys-Jacobs S, Dziem G, Kaatz S, Sanguinetti EL, Bilezikian JP. Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism. N Engl J Med 1997; 337: 1506-1511
79. Simonds WF, James-Newton LA, Agarwal SK, Yang BM, Skarulis MC, Hendy GN, Marx SJ. Familial Isolated Hyperparathyroidism: Clinical and Genetic Characteristics of 36 Kindreds. Medicine 2002; 81: 1-26
80. Stock JL, Brown RS, Baron J, Coderre JA, Mancilla E, De Luca F, Ray K, Mericq MV. Autosomal dominant hypoparathyroidism associated with short stature and premature osteoarthritis. J Clin Endocrinol Metab 1999; 84: 3036-3040
81. Takacs I, Speer G, Bajnok E, Tabak A, Nagy Z, Horvath C, Kovacs K, Lakatos P. Lack of association between calcium-sensing receptor gene "A986S" polymorphism and bone mineral density in Hungarian postmenopausal women. Bone 2002; 30: 849-852
82. Thakker RV. Diseases associated with the extracellular calcium-sensing receptor. Cell Calcium 2004; 35: 275-282
83. Tan YM, Cardinal J, Franks AH, Mun HC, Lewis N, Harris LB, Prins JB, Conigrave AD. Autosomal dominant hypocalcaemia: a novel activating mutation (E604 K) in the cysteine-rich domain of the calcium-sensing receptor. J Clin Endocrinol Metab 2003; 88: 605-610
84. Uckun-Kitapci A, Underwood LE, Zhang J, Moats-Staats B. A novel mutation (E767 K) in the second extracellular loop of the calcium sensing receptor in a family with autosomal dominant hypocalcemia. Am J Med Genet 2005; 132: 125-129
85. Vargas-Poussou R, Huang C, Hulin P, Houillier P, Jeunemaître X, Paillard M, Planelles G, Dechaux M, Miller RT, Antignac C. Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. J Am Soc Nephrol 2002; 13: 2259-2266
86. Vigouroux C, Bourut C, Guerci B, Ziegler O, Magre J, Capeau J, Meyer L. A new missense mutation in the calcium-sensing receptor in familial benign hypercalcaemia associated with partial lipoatrophy and insulin resistant diabetes. Clin Endocrinol (Oxf) 2000; 53: 393-398
87. Waller S, Kurzawinski T, Spitz L, Thakker R, Cranston T, Pearce S, Cheetham T, van't Hoff WG. Neonatal severe hyperparathyroidism: genotype/phenotype correlation and the use of pamidronate as rescue therapy. Eur J Pediatr 2004; 163: 589-594
88. Ward BK, Cameron FJ, Magno AL, McDonnell CM, Stuckey BG, Ratajczak T. A novel homozygous deletion in the calcium-sensing receptor ligand-binding domain associated with neonatal severe hyperparathyroidism. J Pediatr Endocrinol Metab 2006; 19: 93-100
89. Ward BK, Stuckey BG, Gutteridge DH, Laing NG, Pullan PT, Ratajczak T. A novel mutation (L174R) in the Ca2+-sensing receptor gene associated with familial hypocalciuric hypercalcemia. Hum Mutat 1997; 10: 233-235
90. Ward BK, Magno AL, Davis EA, Hanyaloglu AC, Stuckey BG, Burrows M, Eidne KA, Charles AK, Ratajczak T. Functional deletion of the calcium-sensing receptor in a case of neonatal severe hyperparathyroidism. J Clin Endocrinol Metab 2004; 89: 3721-3730
91. Warner J, Epstein M, Sweet A, Singh D, Burgess J, Stranks S, Hill P, Perry-Keene D, Learoyd D, Robinson B, Birdsey P, Mackenzie E, Teh BT, Prins JB, Cardinal J. Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications. J Med Genet 2004; 41: 155-160
92. Watanabe T, Bai M, Lane CR, Matsumoto S, Minamitani K, Minagawa M, Niimi H, Brown EM, Yasuda T. Familial hypoparathyroidism: Identification of a novel gain of function mutation in transmembrane domain 5 of the calcium-sensing receptor. J Clin Endocrinol Metab 1998; 83: 2497-2502
93. Watanabe S, Fukumoto S, Chang H, Takeuchi Y, Hasegawa Y, Okazaki R, Chikatsu N, Fujita T. Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet 2002; 360: 692-694
94. Wystrychowski A, Pidasheva S, Canaff L, Chudek J, Kokot F, Wiecek A, Hendy GN. Functional characterization of calcium-sensing receptor codon 227 mutations presenting as either familial (benign) hypocalcrin. J Clin Endocrin Metab 2005; 90: 864-870
95. Yamauchi M, Sugimoto T, Yamaguchi T, Yano S, Kanzawa M, Kobayashi A, Chihara K. Association of polymorphic alleles of the calcium-sensing receptor gene with the clinical severity of primary hyperparathyroidism. Clin Endocrinol 2001; 55: 373-379
96. Yano S, Sugimoto T, Kanzawa M, Tsukamoto T, Hattori T, Chihara K. Association of polymorphic alleles of the calcium-sensing receptor gene with parathyroid hormone secretion in hemodialysis patients. Nephron 2000; 85: 317-323
97. Young R, Wu F, Van de Water N, Ames R, Gamble G, Reid IR. Calcium-sensing receptor gene A986S polymorphism and responsiveness to calcium supplementationin postmenopausal women. J Clin Endonol Metab 2003; 88: 697-700